Compare HTHT & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTHT | MDGL |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 10.0B |
| IPO Year | 2010 | 2005 |
| Metric | HTHT | MDGL |
|---|---|---|
| Price | $51.14 | $438.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | $52.13 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 1.4M | 326.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | N/A | ★ 41.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $180,133,000.00 |
| Revenue This Year | $7.33 | $58.70 |
| Revenue Next Year | $6.58 | $46.88 |
| P/E Ratio | $30.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.20 | $265.00 |
| 52 Week High | $56.53 | $615.00 |
| Indicator | HTHT | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 42.04 |
| Support Level | $46.93 | $416.43 |
| Resistance Level | $55.89 | $446.51 |
| Average True Range (ATR) | 1.47 | 16.19 |
| MACD | -0.45 | 2.27 |
| Stochastic Oscillator | 10.80 | 61.72 |
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.